Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes for the Treatment of Degenerative Lumbosacral Disc Disease.

NCT07222787 is registered in ClinicalTrials.gov with Providence Medical Technology, Inc. as lead sponsor.

NCT NCT07222787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes for the Treatment of Degenerative Lumbosacral Disc Disease.
Lead sponsor
Providence Medical Technology, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2025
Completion date
July 1, 2029
Enrollment
250 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative lumbar disc disease, radiculopathy lumbar